After CoreWeave (CRWV) announced an agreement to acquire Core Scientific (CORZ) in an all-stock transaction, Jefferies notes that Core Scientific’s share price fell following the acquisition announcement, which the firm attributes to some investors being disappointed by the all-stock deal and the absence of a collar or a cash component to protect against CoreWeave’s volatile stock price. The firm argues that the selloff reflects the risk that CoreWeave’s stock price may be below a $130-$185 range by Q4, which it notes is a view that Jefferies does not share. The firm, which adds that it thinks the deals is a positive outcome for Core Scientific shareholders, assuming that CoreWeave shares “hang on at these levels,” has Buy ratings on both stocks with a $16 price target on Core Scientific and $180 price target on CoreWeave.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- CoreWeave selloff reflects price volatility risk, says Jefferies
- Core Scientific Inc and CRWV Merger: Cost Savings and Strategic Benefits Drive Buy Rating
- Barclays constructive on CoreWeave’s acquisition of Core Scientific
- AI Daily: CoreWeave to acquire Core Scientific in all-stock deal
- Core Scientific downgraded to Neutral from Buy at Roth Capital
